Recent Publications

Name of ArticleDateWebsite/ Publication
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study10/18/2023Read More
Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching-adjusted indirect comparison method8/16/2023Read More
Real‐world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non‐interventional, post‐authorization safety study8/16/2023Read More
Effects of PK‐guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A8/8/2023Read More
A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.6/20/2023Read More
Plasma gastric biomaker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials6/6/2023Read More
New directions to develop therapies for people with hemophilia6/3/2023Read More
Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance4/1/2023Read More
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate3/15/2023Read More
Trends in prescribing practices for management of haemophilia: 1999–20213/15/2023Read More
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders3/15/2023Read More
Depression and anxiety in persons with von Willebrand disease3/1/2023Read More
A need to increase von Willebrand disease awareness: – A global initiative to help address this gap3/1/2023Read More
Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF: Ag ratio and clinical significance2/14/2023Read More
Costs and Impact of Disease in Adults with Sickle Cell Disease: A Pilot Study1/19/2023Read More
Variability in ISTH-BAT score with normal ageing in healthy females; contributory factors and clinical significance12/27/2022Read More
Joint Status and Bleeding Phenotype Characterization in Severe and Non-Severe Hemophilia A and B11/15/2022Read More
Atenativ, a Plasma-Derived Antithrombin Concentrate, Used in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Parturition: Study Description (NCT04918173)11/15/2022Read More
Hereditary Antithrombin Deficiency Pilot Project Registry from the American Thrombosis and Hemostasis Network (ATHN)11/15/2022Read More
Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure10/05/2022Read More
A need to increase von Willebrand disease awareness: vwdtest. com–A global initiative to help address this gap10/1/2022Read More
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A8/24/2022Read More
Sixth Åland Island Conference on von Willebrand disease7/21/2022Read More
The GOAL‐Hēm journey: Shared decision making and patient‐centred outcomes6/21/2022Read More
Characterization of Laboratory Coagulation Parameters and Risk Factors for Intraventricular Hemorrhage in Extremely Premature Neonates5/7/2022Read More
A Single-Arm, Long-Term Efficacy and Safety Study of Subcutaneous Romiplostim in Children with Immune Thrombocytopenia4/13/2022Read More
Molecular pathogenesis and heterogeneity in type 3 VWD families in US Zimmerman program3/28/2022Read More
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP3/10/22Read More
Quality of life in a large multinational haemophilia B cohort (The B‐Natural study)–Unmet needs remain3/8/2022Read More
A challenging case of heparin-induced skin necrosis without thrombocytopenia3/1/2022Read More
Eculizumab for refractory thrombosis in antiphospholipid syndrome2/22/2022Read More
Time is Blood: The Impact of Diagnostic Delays on Acquired Hemophilia A2/9/2022Read More
Incorporating the patient voice and patient engagement in GOAL‐Hēm: Advancing patient‐centric hemophilia care2/7/2022Read More
Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy1/1/2022Read More

Clinical Resources

BCDI works alongside many national healthcare experts when creating guidelines for treatment, care and communication for our patients. We believe it is important for primary care providers and referring providers to have access to valuable community resources. Please see the below resources to learn more.

National Bleeding Disorders Foundation's Medical and Scientific Advisory Council (MASAC)Read More
Platelet Disorder Support AssociationRead More
American Thrombosis and Hemostasis NetworkRead More
Centers for Disease Control and PreventionRead More

Clinical Team Opportunities

Job PositionLocation
Staff HematologistPeoria, IL